Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationale for combination antifungal therapy.

R E Lewis1, D P Kontoyiannis

  • 1Department of Clinical Sciences and Administration, University of Houston College of Pharmacy Texas Medical Center, 77030-4095, USA.

Pharmacotherapy
|August 15, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients.

Transplantation and cellular therapy·2021
Same author

Combination antifungal therapy for breakthrough invasive mould disease in patients with haematological malignancies: when management reasoning eclipses evidence-based medicine.

The Journal of antimicrobial chemotherapy·2020
Same author

Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Influence of Certain Processing Steps on Attachment of Microorganisms to Pork Skin <sup>1</sup>.

Journal of food protection·2019
Same author

Immunosuppressed Adult Zebrafish Model of Mucormycosis.

Antimicrobial agents and chemotherapy·2018
Same author

Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes.

Journal of clinical microbiology·2018
Same journal

Comment on "Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis".

Pharmacotherapy·2026
Same journal

Response to Comment on "Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis".

Pharmacotherapy·2026
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
See all related articles

Antifungal drug combinations are explored to improve treatment for invasive fungal infections. However, clinical trial data supporting these combinations is limited, with ongoing debate about their effectiveness and interactions.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Rising incidence of invasive fungal infections necessitates improved therapeutic strategies.
  • Current antifungal agents have limitations, leading to poor patient outcomes.
  • Antifungal drug combinations are proposed to enhance efficacy against various fungal infections.

Purpose of the Study:

  • To review the current state of evidence for antifungal drug combinations.
  • To identify principles guiding the use of combination antifungal therapy.
  • To address the lack of consensus on synergistic or antagonistic effects of these combinations.

Main Methods:

  • Literature review of available data on antifungal drug combinations.
  • Analysis of clinical trial data, where available.

Related Experiment Videos

  • Assessment of in vitro and in vivo studies on drug interactions.

    • Main Results:

    • Controlled clinical trial data supporting antifungal combinations is sparse, except for cryptococcal meningitis.
    • Significant lack of consensus exists regarding the synergistic or antagonistic effects of various combinations.
    • Several underlying principles for effective combination therapy have been identified based on existing data.

    Conclusions:

    • Combination antifungal therapy holds promise but requires more robust clinical validation.
    • Further research is needed to establish optimal drug pairings and understand their interactions.
    • Evidence-based guidelines are necessary to direct the clinical application of antifungal drug combinations.